Vanderbilt Vaccine CRS — Nashville, Tennessee

Vanderbilt Vaccine CRS is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Vanderbilt Vaccine CRS has participated in 18 clinical trials.

Therapeutic areas: HIV Infections, SARS-CoV-2 Infection, HIV Seronegativity.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Vaccine CRS?

Vanderbilt Vaccine CRS has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Vaccine CRS conducted?

Vanderbilt Vaccine CRS has 18 clinical trials on record. Their work covers HIV Infections, SARS-CoV-2 Infection, HIV Seronegativity.

Is Vanderbilt Vaccine CRS accredited by Crixeo Health?

Yes — Vanderbilt Vaccine CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Vanderbilt Vaccine CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.